Pharma

Can Collaborative Inspections Speed Up Pharmaceutical Approvals?
Manufacturing Can Collaborative Inspections Speed Up Pharmaceutical Approvals?

PCI Pharma Services, a global Contract Development and Manufacturing Organization (CDMO), has set a precedent by becoming the first to complete the International Coalition of Medicines Regulatory Authorities (ICMRA) inspection at its Bedford, New Hampshire campus. This milestone was achieved under

Aurobindo Pharma Expands China Operations and Boosts Pen-G Production
Manufacturing Aurobindo Pharma Expands China Operations and Boosts Pen-G Production

Aurobindo Pharma, a prominent pharmaceutical manufacturer based in Hyderabad, India, is making significant strides to expand its global footprint. The company is on the verge of commencing production at its new facility in China, while also substantially increasing the output capacity of its Pen-G

NHS Requires Certification for Responsible Antibiotic Manufacturing
Manufacturing NHS Requires Certification for Responsible Antibiotic Manufacturing

The UK's National Health Service (NHS) has set a new standard for pharmaceutical companies looking to supply antimicrobial products. Companies must now demonstrate responsible antibiotic manufacturing by obtaining the BSI Kitemark certification. This certification is aimed at ensuring that

New Therapies Transforming Atopic Dermatitis Treatment Landscape
Manufacturing New Therapies Transforming Atopic Dermatitis Treatment Landscape

The treatment landscape for atopic dermatitis (AD) is rapidly evolving, highlighted by the recent approvals of new therapies designed to address unmet medical needs. These advancements have generated considerable excitement in the medical community, as they hold the potential to significantly

Freudenberg Medical Expands Biopharma Line with Single-Use Assemblies
Manufacturing Freudenberg Medical Expands Biopharma Line with Single-Use Assemblies

Freudenberg Medical Expands Biopharma Line with Single-Use Assemblies Freudenberg Medical has broadened its biopharma product portfolio to include custom single-use assemblies, a strategic move that leverages the company's extensive expertise in silicone extrusion and molding processes. This

Can IDT's Strategic Focus Drive Sustained Financial Success in 2024?
Manufacturing Can IDT's Strategic Focus Drive Sustained Financial Success in 2024?

The June 2024 quarter marked a period of substantial financial growth and strategic advancements for Melbourne-based pharmaceutical manufacturer IDT. The company's impressive performance can be attributed to its focus on three core pillars: Advanced Therapies, Active Pharmaceutical Ingredient

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later